Evidence map›Paper›PMID 28938537›Full record

ArticleOncotarget2017

MiR-590-3p promotes proliferation and metastasis of colorectal cancer via Hippo pathway.

Zhen-Qiang Sun, Ke Shi, Quan-Bo Zhou, Xiang-Yue Zeng, Jinbo Liu, Shuai-Xi Yang, Qi-San Wang, Zhen Li, Gui-Xian Wang, Jun-Min Song and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. OncoTargets and therapy · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Zhen-Qiang Sun *Department of Anorectal Surgery, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China.
Ke Shi *Department of Orthopedic Surgery, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China.
Quan-Bo Zhou *Department of Anorectal Surgery, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China.
Xiang-Yue ZengDepartment of Gastrointestinal Surgery, Affiliated Tumor Hospital, Xinjiang Medical University, Urumqi 830011, China.
Jinbo LiuDepartment of Anorectal Surgery, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China.
Shuai-Xi YangDepartment of Anorectal Surgery, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China.
Qi-San WangDepartment of Gastrointestinal Surgery, Affiliated Tumor Hospital, Xinjiang Medical University, Urumqi 830011, China.
Zhen LiDepartment of Anorectal Surgery, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China.
Gui-Xian WangDepartment of Anorectal Surgery, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China.
Jun-Min SongDepartment of Anorectal Surgery, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China.
Wei-Tang YuanDepartment of Anorectal Surgery, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China.
Hai-Jiang WangDepartment of Anorectal Surgery, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China.
First Affiliated Hospital of Zhengzhou University · CNTumor Hospital of Xinjiang Medical University · CNXinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Studies reported that miR-590-3p was involved in human cancer progression. However, its roles of oncogene or anti-oncogene in malignancies still remain elusive. This study was aimed to investigate the effect of miR-590-3p on the cell proliferation and metastasis via Hippo pathway in colorectal cancer (CRC). In our study, miR-590-3p was demonstrated highly expressed in CRC tissues, compared with adjacent normal tissues (

Indexed as

colorectal cancerHippo pathwaymetastasismiR-590-3pproliferation

Identifiers

PMID28938537
PMCPMC5601633
OpenAlexW2739216367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.